Literature DB >> 9557652

Absence of macrophage inflammatory protein-1alpha prevents the development of blinding herpes stromal keratitis.

T M Tumpey1, H Cheng, D N Cook, O Smithies, J E Oakes, R N Lausch.   

Abstract

Prior studies in our laboratory have suggested that the CC chemokine macrophage inflammatory protein-1alpha (MIP-1alpha) may be an important mediator in the blinding ocular inflammation which develops following herpes simplex virus type 1 (HSV-1) infection of the murine cornea. To directly test this hypothesis, MIP-1alpha-deficient (-/-) mice and their wild-type (+/+) counterparts were infected topically on the scarified cornea with 2.5 x 10(5) PFU of HSV-1 strain RE and subsequently graded for corneal opacity. Four weeks postinfection (p.i.), the mean corneal opacity score of -/- mice was 1.1 +/- 0.3 while that of the +/+ mice was 3.7 +/- 0.5. No detectable infiltrating CD4+ T cells were seen histologically at 14 or 21 days p.i. in -/- animals, whereas the mean CD4+ T-cell count per field (36 fields counted) in +/+ hosts was 26 +/- 2 (P < 0.001). In addition, neutrophil counts in the -/- mouse corneas were reduced by >80% in comparison to the wild-type controls. At 2 weeks p.i., no interleukin-2 or gamma interferon could be detected in six of seven -/- mice, whereas both T-cell cytokines were readily demonstrable in +/+ mouse corneas. Also, MIP-2 and monocyte chemoattractant protein-1 protein levels were significantly lower in MIP-1alpha -/- mouse corneas than in +/+ host corneas, suggesting that MIP-1alpha directly, or more likely indirectly, influences the expression of other chemokines. Interestingly, despite the paucity of infiltrating cells, HSV-1 clearance from the eyes of -/- mice was not significantly different from that observed in +/+ hosts. We conclude that MIP-1alpha is not needed to control virus growth in the cornea but is essential for the development of severe stromal keratitis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9557652      PMCID: PMC109592          DOI: 10.1128/JVI.72.5.3705-3710.1998

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Macrophage inflammatory protein-1alpha (MIP-1alpha) is required for the efferent phase of pulmonary cell-mediated immunity to a Cryptococcus neoformans infection.

Authors:  G B Huffnagle; R M Strieter; L K McNeil; R A McDonald; M D Burdick; S L Kunkel; G B Toews
Journal:  J Immunol       Date:  1997-07-01       Impact factor: 5.422

Review 2.  Chemokines and lymphocyte biology.

Authors:  J A Hedrick; A Zlotnik
Journal:  Curr Opin Immunol       Date:  1996-06       Impact factor: 7.486

3.  An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis.

Authors:  W J Karpus; N W Lukacs; B L McRae; R M Strieter; S L Kunkel; S D Miller
Journal:  J Immunol       Date:  1995-11-15       Impact factor: 5.422

4.  Experimental Listeria meningoencephalitis. Macrophage inflammatory protein-1 alpha and -2 are produced intrathecally and mediate chemotactic activity in cerebrospinal fluid of infected mice.

Authors:  J Seebach; D Bartholdi; K Frei; K S Spanaus; E Ferrero; U Widmer; S Isenmann; R M Strieter; M Schwab; H Pfister; A Fontana
Journal:  J Immunol       Date:  1995-11-01       Impact factor: 5.422

5.  Neutrophil-mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea.

Authors:  T M Tumpey; S H Chen; J E Oakes; R N Lausch
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

6.  Protective antibody therapy is associated with reduced chemokine transcripts in herpes simplex virus type 1 corneal infection.

Authors:  Y H Su; X T Yan; J E Oakes; R N Lausch
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

Review 7.  The role of MIP-1 alpha in inflammation and hematopoiesis.

Authors:  D N Cook
Journal:  J Leukoc Biol       Date:  1996-01       Impact factor: 4.962

8.  Resolution of HSV corneal infection in the absence of delayed-type hypersensitivity.

Authors:  R N Lausch; W R Kleinschradt; C Monteiro; S G Kayes; J E Oakes
Journal:  Invest Ophthalmol Vis Sci       Date:  1985-11       Impact factor: 4.799

9.  Recovery from lethal herpes simplex virus type 1 infection is mediated by cytotoxic T lymphocytes.

Authors:  H S Larsen; R G Russell; B T Rouse
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

10.  Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties.

Authors:  S D Wolpe; G Davatelis; B Sherry; B Beutler; D G Hesse; H T Nguyen; L L Moldawer; C F Nathan; S F Lowry; A Cerami
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

View more
  50 in total

Review 1.  Type I interferons and herpes simplex virus infection: a naked DNA approach as a therapeutic option?

Authors:  S Noisakran; D J Carr
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 2.  Molecular machinations: chemokine signals in host-pathogen interactions.

Authors:  S W Chensue
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

3.  Pathogenesis of herpes simplex virus type 1-induced corneal inflammation in perforin-deficient mice.

Authors:  E Chang; L Galle; D Maggs; D M Estes; W J Mitchell
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

4.  CXCL1/KC and CXCL5/LIX are selectively produced by corneal fibroblasts and mediate neutrophil infiltration to the corneal stroma in LPS keratitis.

Authors:  Michelle Lin; Eric Carlson; Eugenia Diaconu; Eric Pearlman
Journal:  J Leukoc Biol       Date:  2006-11-16       Impact factor: 4.962

5.  Herpes simplex virus type 1 induction of chemokine production is unrelated to viral load in the cornea but not in the nervous system.

Authors:  Daniel J J Carr; Iain L Campbell
Journal:  Viral Immunol       Date:  2006       Impact factor: 2.257

Review 6.  Corneal ulceration in pediatric patients: a brief overview of progress in topical treatment.

Authors:  Serina Stretton; Usha Gopinathan; Mark D P Willcox
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

7.  Mapping of genes involved in murine herpes simplex virus keratitis: identification of genes and their modifiers.

Authors:  Kazumi Norose; Akihiko Yano; Xiang-Ming Zhang; Elizabeth Blankenhorn; Ellen Heber-Katz
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

8.  Conjunctival macrophage-mediated influence of the local and systemic immune response after corneal herpes simplex virus-1 infection.

Authors:  Dirk Bauer; Andreas Schmitz; Nico Van Rooijen; Klaus-Peter Steuhl; Arnd Heiligenhaus
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

9.  Exacerbation of corneal scarring in HSV-1 gK-immunized mice correlates with elevation of CD8+CD25+ T cells in corneas of ocularly infected mice.

Authors:  Sariah J Allen; Kevin R Mott; Alexander V Ljubimov; Homayon Ghiasi
Journal:  Virology       Date:  2010-01-18       Impact factor: 3.616

Review 10.  Ocular tropism of respiratory viruses.

Authors:  Jessica A Belser; Paul A Rota; Terrence M Tumpey
Journal:  Microbiol Mol Biol Rev       Date:  2013-03       Impact factor: 11.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.